A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer
Condition(s):Cervical Cancer; Endometrial Cancer; Advanced CancerLast Updated:April 14, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Cervical Cancer; Endometrial Cancer; Advanced CancerLast Updated:April 14, 2023Recruiting
Condition(s):Viral Infections; Bone Marrow Transplant InfectionLast Updated:September 21, 2023Active, not recruiting
Condition(s):Prophylaxis of Ross River Virus InfectionLast Updated:October 9, 2015Completed
Condition(s):Influenza Caused by Unspecified Influenza VirusLast Updated:December 27, 2012Unknown status
Condition(s):West Nile VirusLast Updated:November 6, 2011Completed
Condition(s):Respiratory Virus InfectionLast Updated:October 31, 2012Completed
Condition(s):InfluenzaLast Updated:April 16, 2014Completed
Condition(s):Hematopietic Stem Cell Transplantation; Blood Virome; RNA Virus Infections; DNA Virus InfectionsLast Updated:January 20, 2021Completed
Condition(s):InfluenzaLast Updated:October 11, 2023Completed
Condition(s):Infection in Solid Organ Transplant Recipients; Complications of Organ Transplant; Respiratory Viral InfectionLast Updated:December 16, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.